Rivervest Venture Management LLC

Investment Portfolio & 13F Holdings Analysis

About

RiverVest Venture Management LLC is an institutional investment manager that filed its latest Form 13F for 2024Q3, reporting 3 holdings worth $6.8 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-10-30
Total Holdings: 3
Total Value: 6838040
Accession Number: 0001104659-24-112539
Form Type: 13F-HR
CIK: 0001812549
Manager Name: Rivervest Venture Management LLC

Data Enrichment

67% identified

2 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

3 positions • $6,838.04K total value

3 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

75974E103

2534220(+0.0%)

Value:

$4.3B(+12.6%)

SPRUCE BIOSCIENCES, INC.

SPRB|85209E109

2936281(+0.0%)

Value:

$1.4B(-8.3%)

Xilio Therapeutics, Inc.

XLO|98422T100

1441444(+0.0%)

Value:

$1.1B(-16.9%)

Instrument	Shares		Other Manager	Value
(cusip75974E103)✕	2.5M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$4.3B	QoQ +12.58% (+$482) YoY-
Spruce Biosciences, Inc.(SPRBcusip85209E109)	2.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.4B	QoQ -8.26% (-$126) YoY-
Xilio Therapeutics, Inc.(XLOcusip98422T100)	1.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.1B	QoQ -16.86% (-$230) YoY-